Morbidity and Mortality in Patients With Hypertrophic Cardiomyopathy: a CALIBER Study

NCT02424994 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 12464

Last updated 2015-04-23

No results posted yet for this study

Summary

The aim of this project is to study the association of a number of demographic and cardiovascular risk factors with death, health care utilisation and systemic embolisation by examining the clinical evolution of hypertrophic cardiomyopathy in a large, community based cohort identified from linked electronic health records.

Conditions

Interventions

OTHER

No intervention

Sponsors & Collaborators

  • Inherited Cardiac Diseases Unit, The Heart Hospital, London

    collaborator UNKNOWN
  • University College, London

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02424994 on ClinicalTrials.gov